Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Goldberg, Hadassah; Miller, Robert; Abdah-Bortnyak, Roxolyana; Steiner, Mariana; YILDIZ, FERAH; Meirovitz, Amichav; Villa, Salvador; Poortmans, Philip; Azria, David; Zidan, Jamal; Ozsahin, Mahmut; Abacioglu, Ufuk; Gold, Douglas; Amit, Amnon; Lavie, Ofer; Atahan, I.; Kuten, Abraham

doi:10.1016/j.ygyno.2007.10.037

Outcome after combined modality treatment for uterine papillary serous carcinoma: A study by the Rare Cancer Network (RCN)

Goldberg H., Miller R. C. , Abdah-Bortnyak R., Steiner M., YILDIZ F., Meirovitz A., ...More

GYNECOLOGIC ONCOLOGY, vol.108, no.2, pp.298-305, 2008 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 108 Issue: 2
Publication Date: 2008
Doi Number: 10.1016/j.ygyno.2007.10.037
Title of Journal : GYNECOLOGIC ONCOLOGY
Page Numbers: pp.298-305

Abstract

Objectives. Uterine papillary serous carcinoma (UPSC) is a rare subtype of endometrial carcinoma, characterized by a poor outcome. We sought to better analyze the effect of surgery and adjuvant therapies on this disease.